Carcinogen exposure enhances cancer immunogenicity by blocking the development of an immunosuppressive tumor microenvironment
Journal of Clinical Investigation · 2023
DOI: 10.1172/jci166494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Mei Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer Immunology and Cutaneous Biology Research Center, Department of Dermatology and Center for Cancer Research, Massachusetts General H…. Hauptthemen laut MEDLINE: Carcinogens, Lung Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Carcinogen exposure is strongly associated with enhanced cancer immunogenicity. Increased tumor mutational burden and resulting neoantigen generation have been proposed to link carcinogen exposure and cancer immunogenicity. However, the neoantigen-independent immunological impact of carcinogen exposure on cancer is unknown. Here, we demonstrate that chemical carcinogen-exposed cancer cells fail to establish an immunosuppressive tumor microenvironment (TME), resulting in their T cell-mediated rejection in vivo. A chemical carcinogen-treated breast cancer cell clone that lacked any additional coding region mutations (i.e., neoantigen) was rejected in mice in a T cell-dependent manner. Strikingly, the coinjection of carcinogen- and control-treated cancer cells prevented this rejection, suggesting that the loss of immunosuppressive TME was the dominant cause of rejection. Reduced M-CSF expression by carcinogen-treated cancer cells significantly suppressed tumor-associated macrophages (TAMs) and resulted in the loss of an immunosuppressive TME. Single-cell analysis of human lung cancers revealed a significant reduction in the immunosuppressive TAMs in former smokers compared with individuals who had never smoked. These findings demonstrate that carcinogen exposure impairs the development of an immunosuppressive TME and indicate a novel link between carcinogens and cancer immunogenicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cancer Immunology and Cutaneous Biology Research Center, Department of Dermatology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Department of General Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Förderung
- NIH HHS
- NIAMS NIH HHS
- NCI NIH HHS
- NIH Office of the Director
- National Cancer Institute
- Burroughs Wellcome Fund
- Breast Cancer Alliance
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Huang, M., Xia, Y., Li, K., Shao, F., Feng, Z., Li, T., Azin, M., & Demehri, S. (2023). Carcinogen exposure enhances cancer immunogenicity by blocking the development of an immunosuppressive tumor microenvironment. Journal of Clinical Investigation. https://doi.org/10.1172/jci166494
Vancouver
Huang M, Xia Y, Li K, Shao F, Feng Z, Li T, et al. Carcinogen exposure enhances cancer immunogenicity by blocking the development of an immunosuppressive tumor microenvironment. Journal of Clinical Investigation. 2023. doi:10.1172/jci166494
BibTeX
@article{Huang2023,
author = {Huang, Mei and Xia, Yun and Li, Kaiwen and Shao, Feng and Feng, Zhaoyi and Li, Tiancheng and Azin, Marjan and Demehri, Shadmehr},
title = {Carcinogen exposure enhances cancer immunogenicity by blocking the development of an immunosuppressive tumor microenvironment},
journal = {Journal of Clinical Investigation},
year = {2023},
doi = {10.1172/jci166494}
}
EUVIMED